1. Home
  2. NXDT vs VNDA Comparison

NXDT vs VNDA Comparison

Compare NXDT & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NexPoint Diversified Real Estate Trust

NXDT

NexPoint Diversified Real Estate Trust

HOLD

Current Price

$5.26

Market Cap

286.8M

Sector

Finance

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$4.99

Market Cap

301.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NXDT
VNDA
Founded
2012
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
286.8M
301.1M
IPO Year
2006
2005

Fundamental Metrics

Financial Performance
Metric
NXDT
VNDA
Price
$5.26
$4.99
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $14.90
AVG Volume (30 Days)
131.9K
★ 623.3K
Earning Date
01-01-0001
05-06-2026
Dividend Yield
★ 9.66%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
$85,965,000.00
★ $216,105,000.00
Revenue This Year
N/A
$21.35
Revenue Next Year
N/A
$37.40
P/E Ratio
★ N/A
N/A
Revenue Growth
3.30
★ 8.72
52 Week Low
$2.55
$4.27
52 Week High
$5.95
$9.91

Technical Indicators

Market Signals
Indicator
NXDT
VNDA
Relative Strength Index (RSI) 49.37 41.35
Support Level $5.20 $4.94
Resistance Level $5.54 $5.62
Average True Range (ATR) 0.15 0.16
MACD -0.02 -0.01
Stochastic Oscillator 40.13 10.68

Price Performance

Historical Comparison
NXDT
VNDA

About NXDT NexPoint Diversified Real Estate Trust

NexPoint Diversified Real Estate Trust is an externally advised REIT focused on the acquisition, asset management, development, and disposition of opportunistic, value-add investments in real estate properties throughout the United States. The company has two reportable segments: The Diversified reportable segment is focused on investing in various commercial real estate property types and across the capital structure, including but not limited to, equity, mortgage, debt, mezzanine debt and preferred equity. The Hospitality segment is focused on operating and renovating its U.S. located hospitality assets that meet its investment objective and criteria. Its Portfolio includes investments in the single-family rental, self-storage, office, hospitality, life science and multifamily sectors.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: